1. Home
  2. DRD vs AGIO Comparison

DRD vs AGIO Comparison

Compare DRD & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DRD
  • AGIO
  • Stock Information
  • Founded
  • DRD 1895
  • AGIO 2007
  • Country
  • DRD South Africa
  • AGIO United States
  • Employees
  • DRD N/A
  • AGIO N/A
  • Industry
  • DRD Precious Metals
  • AGIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • DRD Basic Materials
  • AGIO Health Care
  • Exchange
  • DRD Nasdaq
  • AGIO Nasdaq
  • Market Cap
  • DRD 2.3B
  • AGIO 2.5B
  • IPO Year
  • DRD N/A
  • AGIO 2013
  • Fundamental
  • Price
  • DRD $27.32
  • AGIO $26.17
  • Analyst Decision
  • DRD Strong Buy
  • AGIO Buy
  • Analyst Count
  • DRD 2
  • AGIO 8
  • Target Price
  • DRD $27.50
  • AGIO $34.86
  • AVG Volume (30 Days)
  • DRD 561.8K
  • AGIO 2.0M
  • Earning Date
  • DRD 01-01-0001
  • AGIO 10-30-2025
  • Dividend Yield
  • DRD 1.73%
  • AGIO N/A
  • EPS Growth
  • DRD 68.66
  • AGIO N/A
  • EPS
  • DRD 1.46
  • AGIO N/A
  • Revenue
  • DRD $443,674,785.00
  • AGIO $44,791,000.00
  • Revenue This Year
  • DRD $18.10
  • AGIO $25.57
  • Revenue Next Year
  • DRD $25.92
  • AGIO $153.24
  • P/E Ratio
  • DRD $18.16
  • AGIO N/A
  • Revenue Growth
  • DRD 26.26
  • AGIO 36.26
  • 52 Week Low
  • DRD $8.38
  • AGIO $22.24
  • 52 Week High
  • DRD $31.91
  • AGIO $62.45
  • Technical
  • Relative Strength Index (RSI)
  • DRD 52.67
  • AGIO 30.37
  • Support Level
  • DRD $26.20
  • AGIO $23.00
  • Resistance Level
  • DRD $29.93
  • AGIO $25.98
  • Average True Range (ATR)
  • DRD 1.24
  • AGIO 2.13
  • MACD
  • DRD -0.00
  • AGIO -2.13
  • Stochastic Oscillator
  • DRD 51.59
  • AGIO 17.66

About DRD DRDGOLD Limited

DRDGold Ltd is a South African gold mining company engaged in surface gold tailings retreatment including exploration, extraction, processing, and smelting. Its reportable operating segments are; Ergo, FWGR, and Corporate office and other reconciling items. The Ergo is a surface gold retreatment operation that treats old slime dams and sand dumps to the south of Johannesburg's central business district as well as the East and Central Rand goldfields, and the FWGR which is a surface gold retreatment operation and treats old slime dams in the West Rand goldfields. The Ergo segment derives a vast majority of the company's revenue.

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.

Share on Social Networks: